GI infections SHEEHY Flashcards
agents associated with inducing C Diff
Agents AGAINST C dff
- Vancomycin
- Metronidazole
- Fidaxomicin
CDI treatment: vancomycin and metronidazole
- • Preferred treatment for severe CDI is vancomycin, equivalent to metronidazole for mild CDI
- Mechanism of action
- A glycopeptide
- Cell wall synthesis inhibitor (D‐Ala‐D‐Ala)
- • Pharmacokinetics
- Oral vancomycin is not absorbed systemically and
- achieves predictably high levels in the colon
- IV vancomycin has no effect
- • Adverse effects
- Red man syndrome
CDI treatment: metronidazole
- • Mostly used for mild CDI, sometimes used in severe cases if oral administration won’t work
- • Mechanism of action
- • A nitroimidazole with selective action against anaerobes
- • Reduced toxic intermediates are incorporated into bacterial DNA
- • Mechanism of action
- • Mechanism of drug activation
- • Non‐enzymatically reduced by reacting with reduced ferredoxi
- Pharmacokinetics
- • Oral and IV administration has wide distribution including crossing the blood‐brain‐barrier
- • Adverse effects and contraindications
- • Disulfiram‐like effect (avoid alcohol)
- • Metallic taste
- • Nausea
- • Disulfiram‐like effect (avoid alcohol)
- • Peripheral neuropathy (dose limiting)
Metronidazole
Metronidazole
- Trade name is Flagyl®
- Kills flagellated pathogens
• Antiprotozoal drug with potent activity against anaerobes
- Adverse effects
- Disulfiram‐like effect (avoid alcohol) • Metallic taste
CDI treatment: fidaxomicin
- CDI treatment: fidaxomicin
- • Shown to be superior to vancomycin in treating recurrences of CDI
- • Spares many anaerobic colonic flora
- • Mechanism of action
- • Bacterial protein synthesis inhibitor, binds sigma subunit of RNA polymerase
- • Pharmacokinetics
- • Given orally, limited distribution outside GI tract
- • Adverse effects and contraindications •
- Well tolerated, limited GI side effects
Helicobacter pylori
Helicobacter pylori
- Most common cause of duodenal ulcers and chronic gastritis
- Bismuth subsalicylate • Pepto‐Bismol®
Metronidazole
Tetracycline
• Protein synthesis inhibitor
- Omeprazole
- Proton pump inhibitor
Trophozoite ‐> binucleated
precyst ‐> tetranucleated cyst
Entamoeba histolytica
Trophozoite ‐> binucleated
precyst ‐> tetranucleated cyst
- Trophozoites invade intestinal mucosa (10%)
- Portal blood circulation
- Liver abscesses
- Pulmonary abscesses and often death
- Pathogenic if red blood cells in cytoplasm (stool sample)
EA Tx
Therapeutic goals:
• Eliminate the invading trophozoites
- • Metronidazole
- • Tinidazole
• Eradicate intestinal carriage of the organism (luminal amebicide)
- • Paromomycin
- • Iodoquinol
• Asymptomatic carriage
- • Cysts or trophozoites without internalized red blood cells
- • Treated with luminal amebicide agents
Entamoeba histolytica treatment: Metronidazole and tinidazole
Metronidazole is the drug of choice in the treatment of extraluminal amebiasis
- • Kills trophozoites but not the cysts of E. histolytica
- • Eradicates intestinal and extraintestinal tissue infections
• Tinidazole
- • Similar activity and similar adverse effects
- • Somewhat better tolerated than metronidazole
• Both metronidazole and tinidazole must be given with a luminal amebicide to ensure eradication of the E. histolytica infection!
Entamoeba histolytica treatment: Paromomycin
- Used as a luminal amebicide, no effect against extraintestinal organisms
- The antiamebic luminal agent of choice in the USA
- Mechanism of action
- • An aminoglycoside antibiotic
- • Irreversible protein synthesis inhibitor
• Pharmacokinetics
- • No significant absorption outside of GI tract
• Adverse effects and contraindications
- • Occasional abdominal distress and diarrhea
Entamoeba histolytica treatment: Iodoquinol
Entamoeba histolytica treatment: Iodoquinol
- Used as a luminal amebicide, no effect against extraintestinal organisms
- Mechanism of action
- • A halogenated hydroxyquinoline
- • Unknown mechanism in E. histolytica
• Pharmacokinetics
- • 90% retained in the intestine and excreted in the feces
• Adverse effects and contraindications
- • Diarrhea, anorexia, nausea, vomiting, abdominal pain,
- headache, rash, pruritus
- Severe neurotoxicity with high dose or prolonged use
- Contraindicated in patients with intolerance to iodine
Giardia lamblia
- Giardia lamblia
- Trophozoite ‐> cyst
- 5% of US adults infected
- • Most asymptomatic
- • Coating of small intestine interferes with fat absorption
- • Stools packed with fat (smelly)
- • Greasy, frothy diarrhea
- • Abdominal gassy distension
- • Cramps
- • No invasion of intestinal wall
- • No blood in the stool!
Giardia lamblia: treatment
- Supportive
- • Correct fluid and electrolyte abnormalities that result from diarrhea
- • Pharmacological agents
- • Tinidazole
- • First line agent
- • Metronidazole?
- • Nitazoxanide
Giardia lamblia treatment: Nitazoxanide
- giardia lamblia treatment: Nitazoxanide
- • Mechanism of action
- • Inhibition of the pyruvate‐ferredoxin oxidoreductase pathway
- • Mechanism of drug activation
- • Prodrug, active metabolite = tizoxanide
- • Pharmacokinetics
- • Rapidly absorbed, excreted in urine and feces
- • Adverse effects and contraindications
- • Nausea, anorexia, flatulence, increased appetite, enlarged salivary glands, yellow eyes, dysuria, bright yellow urine
Cryptosporidium parvum
- • Contaminated water, day care, travelers
- • Oocyst with 4 motile sporozoites
- • Life cycle within intestinal epithelial cells
- • Diarrhea and abdominal pain
- • Self limiting with immunocompetency
- • Immunocompromised
- • Severe life threatening diarrhea • 3‐17 liters per day
Cryptosporidum Parvum: tx
- parvum treatment
- • Antidiarrheal agents
- Loperamide
- Fluid management
- Antimicrobial agents
- Nitazoxanide
- Preferred agent
- Paromomycin
- Nonabsorbable aminoglycoside
- Nitazoxanide
- Dependent on the immune status of the patient
- Immunocompromised patient
- HIV = antiretroviral therapy + nitazoxanide (if needed)
- Other = reduce dose of immunosuppressant + nitazoxanide
Nitazoxanide vs paromomycin in treating C. parvum infection
Nitazoxanide vs paromomycin in treating C. parvum infection
Nitazoxanide has superior efficacy compared with paromomycin in treating C. parvum infection
Helminths
Helminths
- Greek for worm
- Usually macroscopic
- Diagnosis requires visualization of microscopic eggs (in feces)
- Namatodes = round worms
- Platyhelminhes = flat worms
- No immune response to worm
- Response to dead worms and eggs
- Elevation of eosinophils